Impact of Chronic Hepatitis B and D Infection on the Outcomes of Patients with Human Immunodeficiency Virus Infection
Date Issued
2007
Date
2007
Author(s)
DOI
zh-TW
Abstract
Co-infections with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) are common because of sharing similar transmission routes. The influences of HBV infection on the responses to highly active antiretroviral therapy (HAART) and hepatic complications of patients with HIV infection remain uncertain. Taiwan is a hyperendemic area of HBV infection with chronic HBsAg carriage occurred in 15% to 20% of general population. With the introduction of HAART in 1996, improved survival of HIV-infected patients may allow complications and liver deaths occurred related to HBV. To understand the impact of HBV on HIV-infected patients in Taiwan, HIV-infected patients at National Taiwan University Hospital from 1994 to 2005 were studied.
Subjects
B型肝炎病毒
B型肝炎病毒基因型
愛滋病毒
急性肝炎
肝代償失調
D型肝炎病毒
B型肝炎血清標記
B型肝炎疫苗注射
hepatitis B virus
HBV genotype
human immunodeficiency virus
acute hepatitis
liver decompensation
highly active antiretroviral therapy
hepatitis D virus
HBV serological markers
HBV vaccination
SDGs
Type
text
File(s)![Thumbnail Image]()
Loading...
Name
ntu-96-D89421005-1.pdf
Size
23.31 KB
Format
Adobe PDF
Checksum
(MD5):f46ae76251ff6e034806fe63491d99d7